Avecho Biotechnology Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 34

Employees

  • Stock Symbol
  • AVE

Stock Symbol

Avecho Biotechnology General Information

Description

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Contact Information

Website
www.avecho.com.au
Formerly Known As
Greenchip Development Capital, Phosphagenics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Stock Exchange
ASX
Corporate Office
  • 2A Westall Road
  • Unit A8
  • Clayton, Victoria 3168
  • Australia
+61 (03) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avecho Biotechnology Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.32M 3.17B 6.15M

Avecho Biotechnology Financials Summary

In Thousands,
USD 		TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 5,812 5,812 16,535 17,667
Revenue 314 314 835 595
EBITDA (2,176) (2,176) (1,461) (2,234)
Net Income (2,281) (2,281) (1,622) (2,563)
Total Assets 4,987 4,987 2,276 3,803
Total Debt 119 119 167 68
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avecho Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avecho Biotechnology‘s full profile, request access.

Request a free trial

Avecho Biotechnology Executive Team (3)

Name Title Board Seat Contact Info
Paul Gavin Ph.D Chief Executive Officer
Roksan Libinaki Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Avecho Biotechnology Board Members (1)

Name Representing Role Since
0000 0000000 00.0 Self Board Member 000 0000
To view Avecho Biotechnology’s complete board members history, request access »

Avecho Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avecho Biotechnology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avecho Biotechnology‘s full profile, request access.

Request a free trial

Ready to get started?

Request a free trial

Avecho Biotechnology ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Avecho Biotechnology’s complete esg history, request access »

Avecho Biotechnology FAQs

  • When was Avecho Biotechnology founded?

    Avecho Biotechnology was founded in 1992.

  • Who is the founder of Avecho Biotechnology?

    Harry Rosen is the founder of Avecho Biotechnology.

  • Who is the CEO of Avecho Biotechnology?

    Paul Gavin Ph.D is the CEO of Avecho Biotechnology.

  • Where is Avecho Biotechnology headquartered?

    Avecho Biotechnology is headquartered in Clayton, Australia.

  • What is the size of Avecho Biotechnology?

    Avecho Biotechnology has 34 total employees.

  • What industry is Avecho Biotechnology in?

    Avecho Biotechnology’s primary industry is Drug Discovery.

  • Is Avecho Biotechnology a private or public company?

    Avecho Biotechnology is a Public company.

  • What is Avecho Biotechnology’s stock symbol?

    The ticker symbol for Avecho Biotechnology is AVE.

  • What is the current market cap of Avecho Biotechnology?

    The current market capitalization of Avecho Biotechnology is $8.32M.

  • What is Avecho Biotechnology’s current revenue?

    The trailing twelve month revenue for Avecho Biotechnology is $314K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »